Delivery Order SPE2DB22D2007-SPE2DB25FJ2UE
Award Date 7/3/25
Potential Completion Date 7/25/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,308.12 firm fixed-price delivery order is for the supply of RITUXAN HYCELA 1,400 MG-23,400 11.7ML, with a period of performance through April 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,436.04 firm fixed price delivery order is for 1,400 mg-23,400 11.7 ml units of the medication Rituxan Hycela. The contract has a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which provides a comprehensive global...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,718.02, is for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 21, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RITUXAN HYCELA 1,400 MG-23,400 11.7ML, a pharmaceutical product, with a ceiling value of $22,308.12. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp is the prime contractor and this contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price contract is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML medical supplies. The contract has a period of performance through July 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $7,313.52, is for the delivery of the drug Rituxan Hycela 1,400 mg-23,400 11.7 ml. It is a firm fixed-price delivery order with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RITUXAN HYCELA, a medication used to treat certain types of cancer and autoimmune disorders, with a ceiling value of $22,531.18. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 5, 2025. Amerisourcebergen Drug Corp holds a...
- This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $14,627.04, is for the delivery of 4,565,483,195 units of the biopharmaceutical product Rituxan Hycela 1,400 mg-23,400 11.7 ml. This contract supports the federal government's medical supply needs, providing critical care medications to military treatment...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $2,269.84 for the supply of RITUXIMAB 500MG/50M 1S, a prescription medication. The award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, and is not subject to any set-aside requirements. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,535.52 firm fixed-price delivery order is for the supply of 500mg/50mL vials of the drug Rituximab, which is used to treat certain types of cancer and autoimmune disorders. The contract has an ultimate completion date of September 5, 2024 and was awarded on September 4, 2024. It is not designated as a set-aside contract....